Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,732.70
-13.88
(-0.12%)
NZD/USD
0.6027
-0.0007
(-0.11%)
NZD/EUR
0.5591
-0.0003
(-0.05%)
ALL ORDS
8,038.90
+44.70
(+0.56%)
ASX 200
7,766.20
+44.60
(+0.58%)
OIL
79.84
+0.58
(+0.73%)
Regencell Bioscience Holdings Limited (RGC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.56
-0.17
(-2.97%)
At close: 04:00PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,582
1,582
2,512
438.323
386.23
Selling general and administrative
4,692
4,692
5,106
943.039
426.141
Total operating expenses
6,274
6,274
7,618
1,381
812.371
Operating income or loss
-6,274
-6,274
-7,618
-1,381
-812.371
Total other income/expenses net
211.342
211.342
23.215
34.617
-
Income before tax
-6,062
-6,062
-7,595
-1,347
-812.371
Income tax expense
0
0
0
0
0
Income from continuing operations
-6,062
-6,062
-7,595
-1,347
-812.371
Net income
-5,871
-5,871
-7,446
-1,347
-812.371
Net income available to common shareholders
-5,871
-5,871
-7,446
-1,347
-812.371
Basic EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Diluted EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Basic average shares
13,013
13,013
12,806
12,642
12,642
Diluted average shares
13,013
13,013
12,806
12,642
12,642
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.